Centiva Capital, LP - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$94,080
+20.6%
51,692
+145.3%
0.00%0.0%
Q2 2022$78,00021,0760.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders